1. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment
   Jorge A.R. Salvador et al, 2017, European Journal of Medicinal Chemistry CrossRef
2. Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis
   Wei Peng et al, 2023, Toxicology Research CrossRef
3. Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines
   Christopher R. Bodle et al, 2017, Journal of Natural Products CrossRef
4. Progress in Metastasis and Treatment of Osteosarcoma
   Tianhui Song, 2023, International Journal of Biology and Life Sciences CrossRef
5. Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma
   Huayan Tang et al, 2019, Asia-Pacific Journal of Clinical Oncology CrossRef
6. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
   Cheng Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. An Activatable Nano‐Prodrug for Treating Tyrosine‐Kinase‐Inhibitor‐Resistant Non‐Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging
   Xin Xie et al, 2020, Small CrossRef
8. Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma
   Peijun Zhu et al, 2022, Biomolecules CrossRef
9. The Molecular Mechanisms Involved in Suppressing Triple Negative Breast Cancer Using Natural Agents
   Saabira Banu Sahubar Sadik et al, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef
10. Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
    Bikesh K. Nirala et al, 2023, International Journal of Molecular Sciences CrossRef
11. Celastrol pretreatment attenuates rat myocardial ischemia/ reperfusion injury by inhibiting high mobility group box 1 protein expression via the PI3K/Akt pathway
    Suiyang Tong et al, 2018, Biochemical and Biophysical Research Communications CrossRef
12. Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway
    Yibiao Ye et al, 2018, Oncology Letters CrossRef
13. Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis
    Yunpeng Qi et al, 2018, Biological and Pharmaceutical Bulletin CrossRef
14. Resveratrol and Celastrol Loaded Collagen Dental Implants Regulate Periodontal Ligament Fibroblast Growth and Osteoclastogenesis of Bone Marrow Macrophages
    Ruijie Wang et al, 2020, Chemistry & Biodiversity CrossRef
15. Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway
    Yi‑Jiong Li et al, 2017, Experimental and Therapeutic Medicine CrossRef
16. Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways
    Jiabin Zhu et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
17. Proapoptotic Effect of Icariin on Human Ovarian Cancer Cells via the NF-κB/PI3K-AKT Signaling Pathway: A Network Pharmacology-Directed Experimental Investigation
    Jingjing Gao et al, 2022, The American Journal of Chinese Medicine CrossRef
18. Design, synthesis and evaluation of the novel chalcone derivatives with 2,2-dimethylbenzopyran as HIF-1 inhibitors that possess anti-angiogenic potential
    Huashen Xu et al, 2023, European Journal of Medicinal Chemistry CrossRef
19. Bone Microenvironment and Osteosarcoma Metastasis
    Chaofei Yang et al, 2020, International Journal of Molecular Sciences CrossRef
20. Retracted: Knockdown of lncRNA HULC inhibits proliferation, migration, invasion, and promotes apoptosis by sponging miR‐122 in osteosarcoma
    Daliang Kong et al, 2018, Journal of Cellular Biochemistry CrossRef
21. Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology
    Wei Hou et al, 2020, European Journal of Medicinal Chemistry CrossRef
22. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
    Ziyu Ji et al, 2023, MedComm CrossRef
23. Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention
    Christiane Klec et al, 2019, Expert Opinion on Therapeutic Targets CrossRef